Back

D-dimer: a less invasive way to rule out left atrial thrombus

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Anticoagulation in atrial fibrillation: safety and outcomes Oral Anticoagulation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Supang Taerahkun

Ramathibodi Hospital of Mahidol University, Bangkok (Thailand)

6 More presentations in this session

Presentation thumbnail
Atrial fibrillation and frailty related variance in anticoagulation administration among patients with suspected ischaemic heart disease: the AFRAAID, SWEDEHEART study
Doctor S. Ingves (Norrkoping, SE)
Abstract Slides Video
Presentation thumbnail
Timing of anticoagulation therapy resumption among non-valvular atrial fibrillation (NVAF) patients with prior intracranial haemorrhage
Doctor W. Sun (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Anticoagulation strategies and clinical outcomes in atrial fibrillation patients developing renal deterioration during DOAC therapy
Doctor T. Chao (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Net clinical benefit of continued oral anticoagulants after successful AF ablation: a nationwide cohort study
Doctor B. Joung (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Anemia and thrombocytopenia in patients with atrial fibrillation: a nationwide study.
Doctor M. Heikkinen (Helsinki, FI)
Abstract Slides Video

Access the full session

Session thumbnail
Anticoagulation in atrial fibrillation: safety and outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Elevated thrombin generation levels in the left atrial appendage in patients with atrial fibrillation
26 August 2022
thumbnail
Congress Presentation
Prognostic value of age-adjusted d-dimer cutoff thresholds in patients with myocardial infarction treated by percutaneous coronary intervention
30 August 2020
thumbnail
Congress Presentation
Meta-analysis comparing the efficacy and safety of direct acting oral anticoagulants to warfarin in patients with atrial fibrillation with and without diabetes
28 August 2020
thumbnail
Congress Presentation
Predictors of long-term outcomes in patients with intraventricular thrombus.
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources